Medicamen Biotech Limited Share Price & Analysis
₹245.65▼ -3.93%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹245.65
-3.93%
Open
₹—
High
₹261.6
Low
₹243.35
Close
₹245.65
52W High
₹454
52W Low
₹217
Volume
47K
Lot Size
1
Sector
Healthcare
Market Cap
₹370 Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
38.4
Sector P/E
48.9
P/B
1.21
EPS
₹7.06
ROE
3.95%
ROCE
5.43%
D/E Ratio
0.17
Div Yield
0.37%
Book Value
₹203
+
Strengths
- ✓Attractively valued vs sector (P/E 38.4x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.2x)
- ✓Near 52-week low — potential value zone (₹217)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
MEDICAMEQ · as of Mar 2026
Promoters43.16%▲0.17
FII0.12%▲0.06
DII0.69%▼0.18
Public55.99%▼0.05
Govt0.06%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 43.21% | 43.21% | 42.99% | 42.99% | 42.99% | 43.16% |
| FII | 0.22% | 0.12% | 0.06% | 0.06% | 0.06% | 0.12% |
| DII | 0.67% | 0.99% | 1.17% | 1.17% | 0.87% | 0.69% |
| Public | 55.90% | 55.69% | 55.78% | 55.79% | 56.04% | 55.99% |
| Govt | — | — | — | — | 0.06% | 0.06% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend26 May 2026
Dividend - Re 1 Per Share
Dividend18 Sept 2025
Annual General Meeting/Dividend - Re 1 Per Share
Dividend18 Sept 2024
Annual General Meeting/Dividend - Re 1 Per Share
Dividend19 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹46.91 Cr ▼0.6% | ₹47.17 Cr ▲9.6% | ₹43.04 Cr ▲45.4% | ₹29.61 Cr ▼34.4% | ₹45.14 Cr ▲0.9% | ₹44.74 Cr ▲3.9% | ₹43.05 Cr ▼9.0% | ₹47.32 Cr |
| Op. Profit | ₹4.38 Cr ▼15.1% | ₹5.16 Cr ▲11.9% | ₹4.61 Cr ▲386.3% | ₹-1.61 Cr ▼124.0% | ₹6.71 Cr ▲26.4% | ₹5.31 Cr ▲53.9% | ₹3.45 Cr ▼40.0% | ₹5.75 Cr |
| OPM | 9.3% ▼14.6% | 10.9% ▲2.1% | 10.7% ▲296.9% | -5.4% ▼136.6% | 14.9% ▲25.2% | 11.9% ▲48.2% | 8.0% ▼34.1% | 12.2% |
| Net Profit | ₹1.64 Cr ▼22.6% | ₹2.12 Cr ▲32.5% | ₹1.6 Cr ▼14.4% | ₹1.87 Cr ▼36.0% | ₹2.92 Cr ▲220.9% | ₹0.91 Cr ▲13.7% | ₹0.8 Cr ▼60.8% | ₹2.04 Cr |
| EPS (₹) | 1.61 ▼18.3% | 1.97 ▲23.9% | 1.59 ▼16.3% | 1.9 ▼30.4% | 2.73 ▲137.4% | 1.15 ▲8.5% | 1.06 ▼36.9% | 1.68 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹198 Cr ▲21.5% | ₹163 Cr ▼8.9% | ₹179 Cr ▲27.0% | ₹141 Cr ▲22.6% | ₹115 Cr ▲1.8% | ₹113 Cr ▼9.6% | ₹125 Cr ▲1.6% | ₹123 Cr |
| Expenses | ₹178 Cr ▲20.3% | ₹148 Cr ▼5.1% | ₹156 Cr ▲33.3% | ₹117 Cr ▲28.6% | ₹91 Cr ▼2.2% | ₹93 Cr ▼12.3% | ₹106 Cr ▲1.0% | ₹105 Cr |
| Op. Profit | ₹20 Cr ▲42.9% | ₹14 Cr ▼41.7% | ₹24 Cr ▲0.0% | ₹24 Cr ▲0.0% | ₹24 Cr ▲20.0% | ₹20 Cr ▲0.0% | ₹20 Cr ▲17.6% | ₹17 Cr |
| OPM | 10.0% ▲11.1% | 9.0% ▼30.8% | 13.0% ▼23.5% | 17.0% ▼19.0% | 21.0% ▲23.5% | 17.0% ▲6.3% | 16.0% ▲14.3% | 14.0% |
| Other Income | ₹3 Cr ▼50.0% | ₹6 Cr ▲200.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▼50.0% | ₹4 Cr |
| Interest | ₹4 Cr ▲0.0% | ₹4 Cr ▼33.3% | ₹6 Cr ▲100.0% | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Depreciation | ₹7 Cr ▲0.0% | ₹7 Cr ▲0.0% | ₹7 Cr ▲16.7% | ₹6 Cr ▲0.0% | ₹6 Cr ▲100.0% | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr |
| PBT | ₹12 Cr ▲20.0% | ₹10 Cr ▼23.1% | ₹13 Cr ▼23.5% | ₹17 Cr ▼5.6% | ₹18 Cr ▲12.5% | ₹16 Cr ▼11.1% | ₹18 Cr ▲0.0% | ₹18 Cr |
| Tax % | 18.0% ▼47.1% | 34.0% ▲25.9% | 27.0% ▲92.9% | 14.0% ▼22.2% | 18.0% ▼30.8% | 26.0% ▲0.0% | 26.0% ▼16.1% | 31.0% |
| Net Profit | ₹10 Cr ▲42.9% | ₹7 Cr ▼22.2% | ₹9 Cr ▼40.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲25.0% | ₹12 Cr ▼7.7% | ₹13 Cr ▲8.3% | ₹12 Cr |
| EPS (₹) | 7.11 ▲27.2% | 5.59 ▼35.0% | 8.6 ▼26.7% | 11.73 ▼3.9% | 12.2 ▲22.9% | 9.93 ▼8.7% | 10.88 ▲5.8% | 10.28 |
| Div Payout | 14.0% ▼22.2% | 18.0% ▲50.0% | 12.0% ▲33.3% | 9.0% ▲12.5% | 8.0% ▼20.0% | 10.0% ▲100.0% | 5.0% ▼50.0% | 10.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||
| Equity Capital | ₹14 Cr ▲0.0% | ₹14 Cr ▲7.7% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲8.3% | ₹12 Cr ▲0.0% | ₹12 Cr ▲0.0% | ₹12 Cr ▲0.0% | ₹12 Cr |
| Reserves | ₹262 Cr ▲0.0% | ₹262 Cr ▲31.0% | ₹200 Cr ▲3.1% | ₹194 Cr ▲7.2% | ₹181 Cr ▲35.1% | ₹134 Cr ▲10.7% | ₹121 Cr ▲11.0% | ₹109 Cr ▲45.3% | ₹75 Cr |
| Borrowings | ₹48 Cr ▲23.1% | ₹39 Cr ▲14.7% | ₹34 Cr ▲9.7% | ₹31 Cr ▲19.2% | ₹26 Cr ▲0.0% | ₹26 Cr ▲36.8% | ₹19 Cr ▲72.7% | ₹11 Cr ▼8.3% | ₹12 Cr |
| Other Liabilities | ₹49 Cr ▼7.5% | ₹53 Cr ▲6.0% | ₹50 Cr ▼10.7% | ₹56 Cr ▼5.1% | ₹59 Cr ▲11.3% | ₹53 Cr ▲26.2% | ₹42 Cr ▼14.3% | ₹49 Cr ▲28.9% | ₹38 Cr |
| Total Liabilities | ₹372 Cr ▲1.4% | ₹367 Cr ▲23.6% | ₹297 Cr ▲0.7% | ₹295 Cr ▲5.7% | ₹279 Cr ▲23.5% | ₹226 Cr ▲16.5% | ₹194 Cr ▲7.2% | ₹181 Cr ▲32.1% | ₹137 Cr |
| Assets | |||||||||
| Fixed Assets | ₹85 Cr ▼1.2% | ₹86 Cr ▼1.1% | ₹87 Cr ▼5.4% | ₹92 Cr ▼1.1% | ₹93 Cr ▲1.1% | ₹92 Cr ▲2.2% | ₹90 Cr ▲164.7% | ₹34 Cr ▲41.7% | ₹24 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹40 Cr ▲166.7% | ₹15 Cr |
| Investments | ₹0 Cr ▼100.0% | ₹8 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹287 Cr ▲5.1% | ₹273 Cr ▲30.0% | ₹210 Cr ▲3.4% | ₹203 Cr ▲9.1% | ₹186 Cr ▲39.8% | ₹133 Cr ▲27.9% | ₹104 Cr ▼2.8% | ₹107 Cr ▲10.3% | ₹97 Cr |
| Total Assets | ₹372 Cr ▲1.4% | ₹367 Cr ▲23.6% | ₹297 Cr ▲0.7% | ₹295 Cr ▲5.7% | ₹279 Cr ▲23.5% | ₹226 Cr ▲16.5% | ₹194 Cr ▲7.2% | ₹181 Cr ▲32.1% | ₹137 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating CF | — | ₹-8 Cr ▼14.3% | ₹-7 Cr ▼16.7% | ₹-6 Cr ▼250.0% | ₹4 Cr ▼69.2% | ₹13 Cr ▲0.0% | ₹13 Cr ▲225.0% | ₹4 Cr |
| Investing CF | — | ₹-1 Cr ▲83.3% | ₹-6 Cr ▲0.0% | ₹-6 Cr ▲25.0% | ₹-8 Cr ▲55.6% | ₹-18 Cr ▲51.4% | ₹-37 Cr ▼146.7% | ₹-15 Cr |
| Financing CF | — | ₹-1 Cr ▼116.7% | ₹6 Cr ▼79.3% | ₹29 Cr ▲625.0% | ₹4 Cr ▼33.3% | ₹6 Cr ▼68.4% | ₹19 Cr ▲575.0% | ₹-4 Cr |
| Net Cash Flow | — | ₹-11 Cr ▼83.3% | ₹-6 Cr ▼135.3% | ₹17 Cr | ₹0 Cr ▼100.0% | ₹1 Cr ▲120.0% | ₹-5 Cr ▲64.3% | ₹-14 Cr |
| Free Cash Flow | — | ₹-10 Cr ▲23.1% | ₹-13 Cr ▲0.0% | ₹-13 Cr ▼225.0% | ₹-4 Cr ▲20.0% | ₹-5 Cr ▲80.0% | ₹-25 Cr ▼127.3% | ₹-11 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 151d ▼2.6% | 155d ▲38.4% | 112d ▼33.7% | 169d ▼15.5% | 200d ▲17.6% | 170d ▲17.2% | 145d ▲12.4% | 129d |
| Inventory Days | 251d ▼6.3% | 268d ▲14.5% | 234d ▲2.6% | 228d ▲21.3% | 188d ▲596.3% | 27d ▼65.4% | 78d ▲16.4% | 67d |
| Days Payable | 144d ▼21.7% | 184d ▲19.5% | 154d ▼36.1% | 241d ▼20.2% | 302d ▲78.7% | 169d ▼2.3% | 173d ▲29.1% | 134d |
| Cash Conv. Cycle | 259d ▲8.4% | 239d ▲23.8% | 193d ▲23.7% | 156d ▲81.4% | 86d ▲207.1% | 28d ▼45.1% | 51d ▼17.7% | 62d |
| Working Capital Days | 193d ▲3.8% | 186d ▲51.2% | 123d ▼21.2% | 156d ▲6.1% | 147d ▲16.7% | 126d ▼3.1% | 130d ▲12.1% | 116d |
| ROCE | 5.0% ▼16.7% | 6.0% ▼25.0% | 8.0% ▼20.0% | 10.0% ▼16.7% | 12.0% ▼7.7% | 13.0% ▼18.8% | 16.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Medicamen Biotech Limited share price today?▾
Medicamen Biotech Limited (MEDICAMEQ) is currently trading at ₹245.65 on NSE, down 3.93% as of the last market session. Prices update daily after market close on MarketNetra.
Is Medicamen Biotech Limited available in F&O (Futures & Options)?▾
Yes, Medicamen Biotech Limited (MEDICAMEQ) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Medicamen Biotech Limited 52-week high and low?▾
Medicamen Biotech Limited's 52-week high is ₹454 and the 52-week low is ₹217. The current price of ₹245.65 is 45.9% below the 52W high.
What is Medicamen Biotech Limited P/E ratio?▾
Medicamen Biotech Limited's current P/E ratio is 38.4. This indicates the market is paying ₹38.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Medicamen Biotech Limited options?▾
Medicamen Biotech Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade MEDICAMEQ options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.